PURPOSE: We sought to determine what women recall about reproductive health risks (RHR) from cancer therapy at the time of cancer diagnosis in order to identify barriers to reproductive health counseling (RHC) and fertility preservation (FP). METHODS: Data were obtained by surveying 1,041 female cancer survivors from the California Cancer Registry. Inclusion criteria included women age 18-40 with a diagnosis of leukemia, Hodgkin's disease, non-Hodgkin's lymphoma, breast or GI cancer diagnosed between 1993 and 2007. Women were asked to respond to an open-ended question: "what did your doctor tell you about how cancer treatment could affect your ability to get pregnant?" Framework analysis was used to identify themes surrounding patient perceptions of RHC. RESULTS: Of the patients, 51.8 % (361 out of 697) recalled receiving reproductive health counseling and 12.2 % (85 out of 697) recalled receiving FP counseling. Of the patients, 45.3 % (277 out of 612) reported that uncertain prognosis, risk of recurrence or vertical transmission, age, parity, or uncertain desire may have prevented them from receiving timely and essential information on RHRs. Communication barriers included omission of information, failure to disclose RHRs, and presentation of incorrect information on FP. DISCUSSION: In a sample of women diagnosed with cancer of reproductive age, almost half did not recall counseling on RHRs and few recalled FP counseling. Communication barriers between physicians and patients regarding fertility may lead to uninformed (reproductive health) RH decisions. IMPLICATIONS FOR CANCER SURVIVORS: Many women may not receive adequate information about RHRs or FP at the time of cancer diagnosis. Advancements in reproductive technology and emerging organizations that cover financial costs of FP have dramatically changed what options women have to preserve their fertility. Routine and thoughtful RHR and FP counseling, as well as collaborative cancer care will help ensure that women diagnosed with cancer are provided with the services and information they need to make an informed choice about their reproductive future.
PURPOSE: We sought to determine what women recall about reproductive health risks (RHR) from cancer therapy at the time of cancer diagnosis in order to identify barriers to reproductive health counseling (RHC) and fertility preservation (FP). METHODS: Data were obtained by surveying 1,041 female cancer survivors from the California Cancer Registry. Inclusion criteria included women age 18-40 with a diagnosis of leukemia, Hodgkin's disease, non-Hodgkin's lymphoma, breast or GI cancer diagnosed between 1993 and 2007. Women were asked to respond to an open-ended question: "what did your doctor tell you about how cancer treatment could affect your ability to get pregnant?" Framework analysis was used to identify themes surrounding patient perceptions of RHC. RESULTS: Of the patients, 51.8 % (361 out of 697) recalled receiving reproductive health counseling and 12.2 % (85 out of 697) recalled receiving FP counseling. Of the patients, 45.3 % (277 out of 612) reported that uncertain prognosis, risk of recurrence or vertical transmission, age, parity, or uncertain desire may have prevented them from receiving timely and essential information on RHRs. Communication barriers included omission of information, failure to disclose RHRs, and presentation of incorrect information on FP. DISCUSSION: In a sample of women diagnosed with cancer of reproductive age, almost half did not recall counseling on RHRs and few recalled FP counseling. Communication barriers between physicians and patients regarding fertility may lead to uninformed (reproductive health) RH decisions. IMPLICATIONS FOR CANCER SURVIVORS: Many women may not receive adequate information about RHRs or FP at the time of cancer diagnosis. Advancements in reproductive technology and emerging organizations that cover financial costs of FP have dramatically changed what options women have to preserve their fertility. Routine and thoughtful RHR and FP counseling, as well as collaborative cancer care will help ensure that women diagnosed with cancer are provided with the services and information they need to make an informed choice about their reproductive future.
Authors: Joseph M Letourneau; Michelle E Melisko; Marcelle I Cedars; Mitchell P Rosen Journal: Nat Rev Clin Oncol Date: 2010-08-24 Impact factor: 66.675
Authors: Gwendolyn P Quinn; Susan T Vadaparampil; Paul B Jacobsen; Caprice Knapp; David L Keefe; Geri E Bell Journal: J Midwifery Womens Health Date: 2010 Mar-Apr Impact factor: 2.388
Authors: Laura J Esserman; Dan H Moore; Pamela J Tsing; Philip W Chu; Christina Yau; Elissa Ozanne; Robert E Chung; Vickram J Tandon; John W Park; Frederick L Baehner; Stig Kreps; Andrew N J Tutt; Cheryl E Gillett; Christopher C Benz Journal: Breast Cancer Res Treat Date: 2011-05-20 Impact factor: 4.872
Authors: Neeraj K Arora; Ann S Hamilton; Arnold L Potosky; Julia H Rowland; Noreen M Aziz; Keith M Bellizzi; Carrie N Klabunde; Wendy McLaughlin; Jennifer Stevens Journal: J Cancer Surviv Date: 2007-03 Impact factor: 4.442
Authors: Gwendolyn P Quinn; Susan T Vadaparampil; Clement K Gwede; Cheryl Miree; Lindsey M King; Heather B Clayton; Crystal Wilson; Pamela Munster Journal: J Cancer Surviv Date: 2007-06 Impact factor: 4.062
Authors: Katrina F Trivers; Aliza K Fink; Ann H Partridge; Kutluk Oktay; Elizabeth S Ginsburg; Chunyu Li; Lori A Pollack Journal: Oncologist Date: 2014-06-20
Authors: Mary Peavey; Sara Arian; William Gibbons; Karen Lu; David Gershenson; Terri Woodard Journal: J Adolesc Young Adult Oncol Date: 2016-11-15 Impact factor: 2.223
Authors: Alexandra Higgins; Zaraq Khan; Charles C Coddington; Shahrukh K Hashmi; Mehrdad Hefazi; Hassan Alkhateeb; Mark R Litzow; William J Hogan; Elizabeth Cathcart-Rake; Carrie A Thompson; Mrinal M Patnaik Journal: Biol Blood Marrow Transplant Date: 2019-02-15 Impact factor: 5.742
Authors: R Ramphal; S Aubin; P Czaykowski; S De Pauw; A Johnson; S McKillop; D Szwajcer; K Wilkins; P Rogers Journal: Curr Oncol Date: 2016-06-09 Impact factor: 3.677